Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complete or incomplete revascularization in patients with left main culprit lesion acute myocardial infarction with multivessel disease: a retrospective observational study.
Kim SO, Kim HJ, Park JI, Choi KU, Nam JH, Lee CH, Son JW, Park JS, Her SH, Chang KY, Ahn TH, Jeong MH, Rha SW, Kim HS, Gwon HC, Seong IW, Hwang KK, Hur SH, Cha KS, Oh SK, Chae JK, Kim U. Kim SO, et al. Among authors: hwang kk. J Yeungnam Med Sci. 2025;42:18. doi: 10.12701/jyms.2025.42.18. Epub 2024 Dec 19. J Yeungnam Med Sci. 2025. PMID: 39716364 Free article.
Beta-blockers after percutaneous coronary intervention for acute myocardial infarction and non-reduced left ventricular ejection fraction.
Jeong JC, Park JI, Kim BJ, Kim HJ, Choi KU, Nam JH, Lee CH, Son JW, Park JS, Her SH, Chang KY, Ahn TH, Jeong MH, Rha SW, Kim HS, Gwon HC, Seong IW, Hwang KK, Hur SH, Cha KS, Oh SK, Chae JK, Kim U. Jeong JC, et al. Among authors: hwang kk. Front Cardiovasc Med. 2024 Nov 21;11:1447952. doi: 10.3389/fcvm.2024.1447952. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39639979 Free PMC article.
Different diabetogenic effect of statins according to intensity and dose in patients with acute myocardial infarction: a nationwide cohort study.
Lee J, Choi JY, Choi BG, Choi YJ, Park S, Kang DO, Park EJ, Kim JB, Roh SY, Na JO, Choi CU, Kim EJ, Park CG, Jeong MH, Hwang JY, Hur SH, Jeong JO, Oh S, Rha SW; KAMIR NIH Investigators. Lee J, et al. Sci Rep. 2024 Aug 21;14(1):19438. doi: 10.1038/s41598-024-67585-7. Sci Rep. 2024. PMID: 39169014 Free PMC article.
Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study.
Kim M, Ha KH, Lee J, Park S, Oh KS, Bae DH, Lee JH, Kim SM, Choi WG, Hwang KK, Kim DW, Cho MC, Kim DJ, Bae JW. Kim M, et al. Among authors: hwang kk. Korean Circ J. 2024 May;54(5):256-267. doi: 10.4070/kcj.2023.0234. Epub 2024 Mar 13. Korean Circ J. 2024. PMID: 38654455 Free PMC article.
Eligibility and Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure Across the Whole Spectrum of Ejection Fraction in South Korea.
Kim ES, Park SK, Cho DS, Youn JC, Lee HS, Lee HY, Cho HJ, Choi JO, Jeon ES, Lee SE, Kim MS, Kim JJ, Hwang KK, Cho MC, Chae SC, Kang SM, Park JJ, Choi DJ, Yoo BS, Cho JY, Kim KH, Oh BH, Greenberg B, Baek SH. Kim ES, et al. Among authors: hwang kk. Am J Cardiovasc Drugs. 2024 Mar;24(2):313-324. doi: 10.1007/s40256-024-00632-w. Epub 2024 Feb 27. Am J Cardiovasc Drugs. 2024. PMID: 38413500
Real-World Eligibility and Cost-Effectiveness Analysis of Empagliflozin for Heart Failure in Korea.
Kim ES, Park SK, Youn JC, Lee HS, Lee HY, Cho HJ, Choi JO, Jeon ES, Lee SE, Kim MS, Kim JJ, Hwang KK, Cho MC, Chae SC, Kang SM, Park JJ, Choi DJ, Yoo BS, Cho JY, Kim KH, Oh BH, Greenberg B, Baek SH. Kim ES, et al. Among authors: hwang kk. J Korean Med Sci. 2024 Jan 8;39(1):e8. doi: 10.3346/jkms.2024.39.e8. J Korean Med Sci. 2024. PMID: 38193327 Free PMC article.
212 results